Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Hamada

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 9, 2013
[Significance of quantum chemical interactions for medicinal science and design of β-secretase inhibitors]Yoshio Hamada
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Recent progress in prodrug design strategies based on generally applicable modificationsYoshio Hamada
Bioorganic & Medicinal Chemistry Letters|March 1, 2016
Novel prodrugs with a spontaneous cleavable guanidine moietyYoshio Hamada
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
A novel N-terminal degradation reaction of peptides via N-amidinationYoshio Hamada
Biopolymers|November 20, 2015
New directions for protease inhibitors directed drug discoveryYoshio Hamada, Yoshiaki Kiso
Expert Opinion on Drug Discovery|August 10, 2012
The application of bioisosteres in drug design for novel drug discovery: focusing on acid protease inhibitorsYoshio Hamada, Yoshiaki Kiso
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 7, 2007
[Protease inhibitors]Yoshio Hamada, Yoshiaki Kiso
Expert Opinion on Drug Discovery|March 15, 2013
Recent progress in the drug discovery of non-peptidic BACE1 inhibitorsYoshio Hamada, Yoshiaki Kiso
Expert Opinion on Drug Discovery|April 10, 2013
Advances in the identification of β-secretase inhibitorsYoshio Hamada, Yoshiaki Kiso
Methods in Molecular Biology (Clifton, N.J.)|December 28, 2019
Peptidomimetic Synthesis: Drug Discovery for Alzheimer's DiseaseYoshio Hamada, Zyta M Ziora
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 9, 2013
[Significance of quantum chemical interactions for medicinal science and design of β-secretase inhibitors]Yoshio Hamada
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Recent progress in prodrug design strategies based on generally applicable modificationsYoshio Hamada
Bioorganic & Medicinal Chemistry Letters|March 1, 2016
Novel prodrugs with a spontaneous cleavable guanidine moietyYoshio Hamada
Bioorganic & Medicinal Chemistry Letters|February 27, 2016
A novel N-terminal degradation reaction of peptides via N-amidinationYoshio Hamada
Biopolymers|November 20, 2015
New directions for protease inhibitors directed drug discoveryYoshio Hamada, Yoshiaki Kiso
Expert Opinion on Drug Discovery|August 10, 2012
The application of bioisosteres in drug design for novel drug discovery: focusing on acid protease inhibitorsYoshio Hamada, Yoshiaki Kiso
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|December 7, 2007
[Protease inhibitors]Yoshio Hamada, Yoshiaki Kiso
Expert Opinion on Drug Discovery|March 15, 2013
Recent progress in the drug discovery of non-peptidic BACE1 inhibitorsYoshio Hamada, Yoshiaki Kiso
Expert Opinion on Drug Discovery|April 10, 2013
Advances in the identification of β-secretase inhibitorsYoshio Hamada, Yoshiaki Kiso
Methods in Molecular Biology (Clifton, N.J.)|December 28, 2019
Peptidomimetic Synthesis: Drug Discovery for Alzheimer's DiseaseYoshio Hamada, Zyta M Ziora
Pageof 6